Erythropoietin facilitates the return of spontaneous circulation and survival in victims of out-of-hospital cardiac arrest

Resuscitation

Volumn 80, Issue 6, 2009, Pages 631-637

  Grmec, Štefek ^a,b,c,d   Strnad, Matej ^a,b   Kupnik, Dejan ^a,b,d   Sinkovič, Andreja ^b,c,e   Gazmuri, Raúl J ^f  

^a Center for Emergency Medicine Maribor   (Slovenia)

^b UNIVERSITY OF MARIBOR   (Slovenia)

^c UNIVERSITY OF LJUBLJANA   (Slovenia)

^d UNIVERSITY OF MARIBOR   (Slovenia)

^e UNIVERSITY MEDICAL CENTRE MARIBOR   (Slovenia)

^f ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Cardiopulmonary resuscitation; Erythropoietin; Ischemia; Myocardium; Trials

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ARTICLE; COMPRESSION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; END TIDAL CARBON DIOXIDE TENSION; FEMALE; HEART ARREST; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESUSCITATION; SLOVENIA;

AGED; CARDIOPULMONARY RESUSCITATION; CARDIOVASCULAR AGENTS; CORONARY CIRCULATION; ERYTHROPOIETIN; FEMALE; HEART; HEART ARREST; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SODIUM CHLORIDE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 67349285113     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2009.03.010     Document Type: Article

References (35)

1. Cai Z., Manalo D.J., Wei G., et al. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation 108 (2003) 79-85
2. Calvillo L., Latini R., Kajstura J., et al. Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodelling. Proc Natl Acad Sci USA 100 (2003) 4802-4806
3. Moon C., Krawczyk M., Ahn D., et al. Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats. Proc Natl Acad Sci USA 100 (2003) 11612-11617
4. Parsa C.J., Matsumoto A., Kim J., et al. A novel protective effect of erythropoietin in the infarcted heart. J Clin Invest 112 (2003) 999-1007
5. Tramontano A.F., Muniyappa R., Black A.D., et al. Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathway. Biochem Biophys Res Commun 308 (2003) 990-994
6. Cai Z., and Semenza G.L. Phosphatidylinositol-3-kinase signaling is required for erythropoietin-mediated acute protection against myocardial ischemia/reperfusion injury. Circulation 109 (2004) 2050-2053
7. Lipsic E., van der M.P., Henning R.H., et al. Timing of erythropoietin treatment for cardioprotection in ischemia/reperfusion. J Cardiovasc Pharmacol 44 (2004) 473-479
8. Parsa C.J., Kim J., Riel R.U., et al. Cardioprotective effects of erythropoietin in the reperfused ischemic heart: a potential role for cardiac fibroblasts. J Biol Chem 279 (2004) 20655-20662
9. Wright G.L., Hanlon P., Amin K., et al. Erythropoietin receptor expression in adult rat cardiomyocytes is associated with an acute cardioprotective effect for recombinant erythropoietin during ischemia-reperfusion injury. FASEB J 18 (2004) 1031-1033
10. Namiuchi S., Kagaya Y., Ohta J., et al. High serum erythropoietin level is associated with smaller infarct size in patients with acute myocardial infarction who undergo successful primary percutaneous coronary intervention. J Am Coll Cardiol 45 (2005) 1406-1412
11. Bullard A.J., Govewalla P., and Yellon D.M. Erythropoietin protects the myocardium against reperfusion injury in vitro and in vivo. Basic Res Cardiol 100 (2005) 397-403
12. Rafiee P., Shi Y., Su J., et al. Erythropoietin protects the infant heart against ischemia-reperfusion injury by triggering multiple signaling pathways. Basic Res Cardiol 100 (2005) 187-197
13. Nishihara M., Miura T., Miki T., et al. Erythropoietin affords additional cardioprotection to preconditioned hearts by enhanced phosphorylation of glycogen synthase kinase-3 beta. Am J Physiol Heart Circ Physiol 291 (2006) H748-H755
14. Singh D., Kolarova J.D., Wang S., Ayoub I.M., and Gazmuri R.J. Myocardial protection by erythropoietin during resuscitation from ventricular fibrillation. Am J Ther 14 (2007) 361-368
15. Kolarova J.D., Ayoub I.M., and Gazmuri R.J. Cariporide enables hemodynamically more effective chest compression by leftward shift of its flow-depth relationship. Am J Physiol Heart Circ Physiol 288 (2005) H2904-H2911
16. Gazmuri R.J., Ayoub I.M., Hoffner E., and Kolarova J.D. Successful ventricular defibrillation by the selective sodium-hydrogen exchanger isoform-1 inhibitor cariporide. Circulation 104 (2001) 234-239
17. Ayoub I.M., Kolarova J.D., Yi Z., et al. Sodium-hydrogen exchange inhibition during ventricular fibrillation: beneficial effects on ischemic contracture, action potential duration, reperfusion arrhythmias, myocardial function, and resuscitability. Circulation 107 (2003) 1804-1809
18. Ayoub I.M., Kolarova J., Kantola R., Radhakrishnan J., and Gazmuri R.J. Zoniporide preserves left ventricular compliance during ventricular fibrillation and minimizes post-resuscitation myocardial dysfunction through benefits on energy metabolism. Crit Care Med 35 (2007) 2329-2336
19. Huang C.H., Hsu C.Y., Chen H.W., et al. Erythropoietin improves postresuscitation myocardial dysfunction and survival in the asphyxia-induced cardiac arrest model. Shock 28 (2007) 53-58
20. Huang C.H., Hsu C.Y., Tsai M.S., Wang T.D., Chang W.T., and Chen W.J. Cardioprotective effects of erythropoietin on postresuscitation myocardial dysfunction in appropriate therapeutic windows. Crit Care Med 36 (2008) S467-S473
21. Kurth T., Walker A.M., Glynn R.J., et al. Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol 163 (2006) 262-270
22. D'Agostino Jr. R.B. Propensity scores in cardiovascular research. Circulation 115 (2007) 2340-2343
23. Nichol G., Thomas E., Callaway C.W., et al. Regional variation in out-of-hospital cardiac arrest incidence and outcome. JAMA 300 (2008) 1423-1431
24. Duggal C., Weil M.H., Gazmuri R.J., et al. Regional blood flow during closed-chest cardiac resuscitation in rats. J Appl Physiol 74 (1993) 147-152
25. 2 as an indicator of systemic perfusion during cardiopulmonary resuscitation. Crit Care Med 17 (1989) 237-240
26. Orliaguet G.A., Carli P.A., Rozenberg A., Janniere D., Sauval P., and Delpech P. End-tidal carbon dioxide during out-of-hospital cardiac arrest resuscitation: comparison of active compression-decompression and standard CPR. Ann Emerg Med 25 (1995) 48-51
27. Kolar M., Krizmaric M., Klemen P., and Grmec S. Partial pressure of end-tidal carbon dioxide successful predicts cardiopulmonary resuscitation in the field: a prospective observational study. Crit Care 12 (2008) R115
28. Sanders A.B., Kern K.B., Otto C.W., Milander M.M., and Ewy G.A. End-tidal carbon dioxide monitoring during cardiopulmonary resuscitation. JAMA 262 (1989) 1347-1351
29. Takino M., and Okada Y. Firm myocardium in cardiopulmonary resuscitation. Resuscitation 33 (1996) 101-106
30. Kolarova J., Yi Z., Ayoub I.M., and Gazmuri R.J. Cariporide potentiates the effects of epinephrine and vasopressin by nonvascular mechanisms during closed-chest resuscitation. Chest 127 (2005) 1327-1334
31. Shi Y., Rafiee P., Su J., Pritchard Jr. K.A., Tweddell J.S., and Baker J.E. Acute cardioprotective effects of erythropoietin in infant rabbits are mediated by activation of protein kinases and potassium channels. Basic Res Cardiol 99 (2004) 173-182
32. Nishihara M., Miura T., Miki T., et al. Modulation of the mitochondrial permeability transition pore complex in GSK-3beta-mediated myocardial protection. J Mol Cell Cardiol 43 (2007) 564-570
33. Popp E., Vogel P., Teschendorf P., and Bottiger B.W. Effects of the application of erythropoietin on cerebral recovery after cardiac arrest in rats. Resuscitation 74 (2007) 344-351
34. Cariou A., Claessens Y.E., Pene F., et al. Early high-dose erythropoietin therapy and hypothermia after out-of-hospital cardiac arrest: a matched control study. Resuscitation 76 (2008) 397-404
35. Grmec S., Krizmaric M., Mally S., Kozelj A., Spindler M., and Lesnik B. Utstein style analysis of out-of-hospital cardiac arrest-bystander CPR and end expired carbon dioxide. Resuscitation 72 (2007) 404-414